Coordinated action among manufacturers, clinicians, regulators, and policymakers is necessary to address the racial and ethnic bias in pulse oximetry, the authors of an article published in JAMA ...

“Black patients had nearly three times the frequency of occult hypoxemia that was not detected by pulse oximetry as White patients.” The FDA issued a formal warning about pulse oximeters in February ...

The US Food and Drug Administration (FDA) has announced new draft recommendations to improve the accuracy of pulse oximeters – devices used to estimate blood oxygen levels – across the whole ...

Pulse oximeters were invented in 1974, and the evidence of flawed pulse oximeter readings in people with dark skin dates to the 1980s. One study, published in 2022, found that among more than ...

The question of how skin pigmentation affects the performance of pulse oximeters has drawn the U.S. FDA’s close attention for several years, and the agency issued a draft guidance to address these ...

Abstract: Low sidelobe waveform can reduce mutual masking between targets and increase the detection probability of weak targets. A low sidelobe waveform design method based on complementary amplitude ...

The Pulse takes you behind the doors of operating rooms, into the lab with some of the world's foremost scientists, and back in time to explore life-changing innovations. The Pulse delivers ...

The FDA first warned about problems with pulse oximeter accuracy in 2021. CDRH had listed draft guidance on pulse oximeters among its priorities for the 2024 fiscal year but missed the cutoff. While ...

The FDA first warned about problems with pulse oximeter accuracy in 2021. CDRH had listed draft guidance on pulse oximeters among its priorities for the 2024 fiscal year but missed the cutoff.

Around 1 in 100 infants born each year in the U.S. have a heart defect, and pulse oximetry screening is estimated to help single out over 90% of cases. Since 2018, all 50 states and Washington ...